CE Certification Confirms Device Conforms to Medical Device Directive 93/42/EEC BUCKINGHAMSHIRE, UK, JULY 17, 2018 -- Lumendi Ltd., a privately held innovative medical device company, today announced that its subsidiary,...
Read More
Flexible Endoscopic Double Balloon Platform: from concept to human feasibility trial. Sam Sharma*, Kota Momose, Toyooki Sonoda, Reem Z. Sharaiha Weill Cornell Medical College, New York, NY Background: Despite the...
Read More
Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, May 29, 2018 − Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration...
Read More
Lumendi to Present at Digital Medicine & Medtech Showcase WESTPORT, CONN, November 10, 2017 – Lumendi Ltd., a privately held innovative medical device company, announced today that Chief Executive Officer...
Read More
Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery Daniel Seeger Editor with www.surgicalproductsmag.com Surgeons interested in expanding their alternatives in pursuing minimally invasive options need to be attuned to...
Read More
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi, LLC...
Read More
LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part...
Read More
LUMENDI EXPANDS SOCIAL MEDIA PRESENCE WITH NEW YOU TUBE CHANNEL DEDICATED TO ITS DILUMEN™ EIP WESTPORT, CONNECTICUT, October 4, 2017 – Lumendi, LLC (http:/lumendi.com), a wholly owned subsidiary of Lumendi,...
Read More
